Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.495
-0.075-1.64%
Volume:8.34M
Turnover:37.52M
Market Cap:28.24B
PE:5.99
High:4.600
Open:4.600
Low:4.470
Close:4.570
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.99
T/O Rate:0.13%
Dividend:0.22
Dividend Rate:4.85%
EPS(LYR):0.750
ROE:8.32%
ROA:2.64%
PB:0.46
PE(LYR):5.99
PS:0.09

Loading ...

CHINARES PHARMA Announces Board Changes: Guo Chuan Resigns, Zhang Jing Joins as Non-Executive Director

Bulletin Express
·
Jul 13

China Resources Pharma Announces Board Changes: Zhang Jing Appointed as Non-Executive Director

Stock News
·
Jul 13

China Resources Pharmaceutical Files Board, Committee and Disclosure-responsible Management List

Reuters
·
Jul 13

China Resources Pharmaceutical Appoints Zhang Jing as Non-executive Director

Reuters
·
Jul 13

China Resources Pharma Reports No Share Capital Movement for June 2026; Public Float Compliance Maintained

Bulletin Express
·
Jul 02

China Resources Pharmaceutical Declares 2025 Final Dividend of RMB 0.122 a Share

Reuters
·
Jun 30

China Resources Pharmaceutical Unit Sells 2 Billion Yuan Bonds

MT Newswires Live
·
Jun 29

China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon

Bulletin Express
·
Jun 26

China Resources Pharma AGM: All Resolutions Approved, Final Dividend Set at RMB0.122 per Share

Bulletin Express
·
Jun 12

CHINARES PHARMA Keeps Outstanding Shares Flat at 6.28 Billion in May 2026, Affirms Public Float Compliance

Bulletin Express
·
Jun 01

China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3%

MT Newswires Live
·
Jun 01

CHINARES PHARMA Subsidiary Authorized to Issue 5 Billion Yuan in Medium-Term Notes

Stock News
·
May 29

China Resources Pharmaceutical Secures NAFMII Green Light for RMB5.00 Billion Medium-Term Note Programme

Bulletin Express
·
May 29

China Resources Pharma unit registers RMB 5 billion medium-term note programme in China

Reuters
·
May 29

CHINARES PHARMA to Distribute Final Dividend on August 3

Stock News
·
May 19

CHINARES PHARMA Declares HKD 0.139 Final Dividend for FY 2025; Ex-Dividend Date 17 June 2026

Bulletin Express
·
May 19

China Resources Pharmaceutical announces annual general meeting

Reuters
·
May 19

Global Bio-Chem unit wins Shenzhou Bio-tech order for 1,270 tonnes coenzyme Q10 mycelium

Reuters
·
May 08

China Resources Pharma unit CR Pharmaceutical Commercial posts Q1 net profit RMB 455.29 million

Reuters
·
Apr 30

China Resources Pharma unit CR Pharmaceutical Commercial issues RMB 1.4 billion bonds at 1.65%

Reuters
·
Apr 28